{
    "2019-11-22": [
        [
            {
                "time": "",
                "original_text": "高瓴资本全球生物医药行业布局的赛道解析",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "全球",
                        "生物医药",
                        "行业布局",
                        "赛道解析"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【太平洋医药杜佐远团队】经典报告集：我们只想为您甄选牛股",
                "features": {
                    "keywords": [
                        "太平洋医药",
                        "杜佐远团队",
                        "经典报告",
                        "甄选牛股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}